AEZS Aeterna Zentaris Inc.


49,908 Shares Traded
791,119 Average Volume (last 30 days)

as of February 23, 2018 EST IEX Real-Time Price

Short Pain Metrics

Approximate Amount of Money Shorts Have Made on the Day: $1.3 million
If Intiated on the First, Shorts Have Realized a Year to Date Return of:20.25%
If Intiated One Month Ago, Shorts Have Realized a Return of:21.25%
If Initiated Five Days ago, Shorts Have Realized a Return of:3.08%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bearish
50 Day Moving Average Indicator Bearish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 4.24%
Short Interest697.51 thousand
Float16.44 million
Short Ratio0.65
Market Cap$31.07 million
Market Maker ActivityDaily Short Volume


AEterna Zentaris: Licensing Agreement Takes Out Dilution Risk (SeekingAlpha)
Biotech Forum Daily Digest For January 18th (SeekingAlpha)
Your Daily Pharma Scoop: Juno Surges On Takeover Rumors, AEterna Zentaris Achieves Another Milestone, Spark Granted ODD (SeekingAlpha)
Midday Gainers / Losers (1/17/2018) (SeekingAlpha)
Premarket Gainers as of 9:05 am (SeekingAlpha)
Aeterna Zentaris shares halted pending news (SeekingAlpha)
Your Daily Pharma Scoop: Biogen Setback, Ironwood Commences Trial, Vtv Signs 2 Deals (SeekingAlpha)
Biotech Forum Daily Digest: Synergy's CEO Leaves, Shareholders Cheer! (SeekingAlpha)
Midday Gainers / Losers (SeekingAlpha)
Your Daily Pharma Scoop: AEterna Zentaris Gets FDA Nod, Valeant Finalizes Sprout Sale, Roche Gets EC Approval (SeekingAlpha)

Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 1.9%

Earnings Stats

PE Ratio -0.98
Dividend Yield 0%
Peer EarningsEarnings Calendar


200 Day Moving Average $1.8
50 Day Moving Average $2.18
52 Week High $3.75
52 Week Low $0.78

Data provided for free by IEX. Questions? Read the FAQ